| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
![]() | 1 | 2 | |||||
![]() | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
![]() | 10 | 11 | 12 | 13 | 14 | 15 | 16 |
![]() | 17 | 18 | 19 | 20 | 21 | 22 | 23 |
![]() | 24 | 25 | 26 | 27 | 28 | 29 | 30 |

CSL LIMITED (CSL)
Stock Code: CSL
Listing Date: 1994-06-08 00:00:00
Website: http://www.csl.com.au/
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions.
Address:
45 Poplar Road
PARKVILLE
VIC 3052
Phone: (03) 9389 1911
Fax: (03) 9389 1434
Executives & Directors
Miss Elizabeth Alexander, Non Exec. Chairman, Non Exec. Director
Dr Brian A McNamee, Director, Managing Director, CEO
Mr David Anstice, Director
Mr Ian Renard, Non Exec. Director
Mr John Akehurst, Non Exec. Director
Mr Maurice Renshaw, Non Exec. Director
Prof. John Shine, Non Exec. Director
Mr David Simpson, Non Exec. Director
Mr Antoni Cipa, Finance Director
Mr Peter Turvey, General Counsel
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
| Annual General Meeting | Wed, 15 Oct 2008 10:00AM |
|
| Date Payable | Fri, 10 Oct 2008 | |
| Record Date | Mon, 22 Sep 2008 | |
| Ex Div Date | Tue, 16 Sep 2008 | |
| Full Year Results | Wed, 20 Aug 2008 | |
| Date Payable | Mon, 14 Apr 2008 | |
| Record Date | Thu, 20 Mar 2008 | |
| Ex Div Date | Fri, 14 Mar 2008 | |
| Interim Results | Wed, 20 Feb 2008 | |
| Annual General Meeting | Wed, 17 Oct 2007 10:00AM |
|
| Date Payable | Fri, 12 Oct 2007 | |
| Record Date | Fri, 21 Sep 2007 | |
| Ex Div Date | Mon, 17 Sep 2007 | |
| Full Year Results | Wed, 22 Aug 2007 | |
| Date Payable | Fri, 13 Apr 2007 | |
| Record Date | Tue, 20 Mar 2007 | |
| Ex Div Date | Wed, 14 Mar 2007 | |
| Interim Results | Wed, 21 Feb 2007 | |
| Annual General Meeting | Wed, 18 Oct 2006 10:00AM |
|
| Date Payable | Fri, 13 Oct 2006 | |
| Record Date | Fri, 22 Sep 2006 | |
| Ex Div Date | Mon, 18 Sep 2006 | |
| Full Year Results | Wed, 23 Aug 2006 | |
| Date Payable | Thu, 13 Apr 2006 | |
| Record Date | Mon, 20 Mar 2006 | |
| Ex Div Date | Tue, 14 Mar 2006 | |
| Interim Results | Wed, 22 Feb 2006 | |
| Annual General Meeting | Wed, 12 Oct 2005 10:00AM |
|
| Date Payable | Mon, 10 Oct 2005 | |
| Record Date | Mon, 5 Sep 2005 | |
| Ex Div Date | Tue, 30 Aug 2005 |
CSL LIMITED (CSL)
| Change in substantial holding | Mon, 17 Nov 2008 |
| Appendix 3B | Fri, 14 Nov 2008 |
| Appendix 3B | Thu, 30 Oct 2008 |
| Change of Director`s Interest Notice | Tue, 28 Oct 2008 |
| Change of Director`s Interest Notice | Mon, 27 Oct 2008 |
| Appendix 3B | Mon, 27 Oct 2008 |
| Change of Directors Interest Notice | Wed, 22 Oct 2008 |
| Appendix 3B | Tue, 21 Oct 2008 |
| CSL Chairman Address and MDs presentation at AGM | Wed, 15 Oct 2008 |
| Results of Meeting | Wed, 15 Oct 2008 |
| CSL receives FTC request on proposed merger with Talecris | Mon, 13 Oct 2008 |
| Appendix 3B | Mon, 13 Oct 2008 |
| Appendix 3B | Tue, 7 Oct 2008 |
| Form 605 - Ceasing to be a substantial holder | Fri, 26 Sep 2008 |
| Change of Director`s Interest Notice | Thu, 25 Sep 2008 |
| Appendix 3B | Mon, 22 Sep 2008 |
| Update on CSL Share Purchase Plan | Fri, 19 Sep 2008 |
| Notice of Annual General Meeting/Proxy Form | Fri, 12 Sep 2008 |
| Annual Report to shareholders | Fri, 12 Sep 2008 |
| Appendix 3B | Thu, 11 Sep 2008 |
| Appendix 3B | Fri, 5 Sep 2008 |
| Initial Directors Interest Notice | Wed, 3 Sep 2008 |
| Director Appointment/Resignation | Tue, 2 Sep 2008 |
| Form 603 - Becoming a substantial holder | Tue, 2 Sep 2008 |
| Appendix 3B | Fri, 29 Aug 2008 |
| CSL Share Purchase Plan (SPP) | Mon, 25 Aug 2008 |
| Change in substantial holding | Fri, 22 Aug 2008 |
| Form 605 - Ceasing to be a substantial holder | Fri, 22 Aug 2008 |
| Change of Director`s Interest Notice | Fri, 22 Aug 2008 |
| Appendix 3B and section 798A(5)(e) notice | Wed, 20 Aug 2008 |
| Header Correction Appendix 3B and Section 708A(5)(e) notice | Wed, 20 Aug 2008 |
| Appendix 3B | Wed, 20 Aug 2008 |
| Completes institutional equity raising | Thu, 14 Aug 2008 |
| Preliminary Final Report Accounts and Media Release | Wed, 13 Aug 2008 |
| CSL announces agreement to acquire Talecris | Wed, 13 Aug 2008 |
| Trading Halt | Wed, 13 Aug 2008 |
| Change in substantial holding | Thu, 24 Jul 2008 |
| AAH: Arana Therapeutics completes second project with CSL | Thu, 5 Jun 2008 |
| Appendix 3B | Mon, 14 Apr 2008 |
| CSL Half Year Report 2007-08 | Tue, 8 Apr 2008 |
| Appendix 3B | Thu, 20 Mar 2008 |
| Becoming a substantial holder | Tue, 11 Mar 2008 |
| Change of Directors Interest Notice - Appendix 3Y | Tue, 4 Mar 2008 |
| Appendix 3B | Mon, 3 Mar 2008 |
| Appendix 3B | Thu, 21 Feb 2008 |
| CSL Half Yearly Report and Half Year Accounts | Wed, 20 Feb 2008 |
| Unsolicited share offers | Thu, 14 Feb 2008 |
| AAH: Arana Achieves Milestone in Collaboration with CSL | Mon, 4 Feb 2008 |
| Appendix 3B | Thu, 13 Dec 2007 |
| CSL Research and Development Briefing | Thu, 13 Dec 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.
